Poly Medicure Limited (NSE:POLYMED)
1,759.60
+26.60 (1.53%)
Aug 31, 2026, 3:30 PM IST
Poly Medicure Market Cap
Poly Medicure has a market cap or net worth of 178.71 billion as of August 31, 2026. Its market cap has decreased by -15.42% in one year.
Market Cap
178.71B
Enterprise Value
174.40B
Revenue
19.97B
Ranking
n/a
PE Ratio
56.72
Stock Price
1,759.60
ChartMarket Cap Chart
Since November 19, 2004, Poly Medicure's market cap has increased from 324.00M to 178.71B, an increase of 55,056.46%. That is a compound annual growth rate of 33.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 178.71B | -0.72% |
| Dec 31, 2025 | 179.99B | -31.93% |
| Dec 31, 2024 | 264.42B | 84.87% |
| Dec 29, 2023 | 143.03B | 66.54% |
| Dec 30, 2022 | 85.89B | -6.43% |
| Dec 31, 2021 | 91.79B | 105.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.76T |
| Divi's Laboratories | 2.45T |
| Apollo Hospitals Enterprise | 1.28T |
| Zydus Lifesciences | 1.16T |
| Eris Lifesciences | 182.19B |
| OneSource Specialty Pharma | 175.66B |
| Cohance Lifesciences | 172.12B |
| Alivus Life Sciences | 165.72B |